CV Sciences (CVSI)
(Delayed Data from OTC)
$0.05 USD
0.00 (-3.31%)
Updated Sep 13, 2024 03:59 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for CV Sciences, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 16 | 16 | 20 | 24 | 54 |
Cost Of Goods | 9 | 11 | 11 | 13 | 19 |
Gross Profit | 7 | 6 | 9 | 11 | 35 |
Selling & Adminstrative & Depr. & Amort Expenses | 4 | 12 | 27 | 34 | 52 |
Income After Depreciation & Amortization | 3 | -7 | -18 | -23 | -17 |
Non-Operating Income | 0 | 0 | 3 | 0 | 0 |
Interest Expense | 0 | 2 | 0 | 0 | 0 |
Pretax Income | 3 | -8 | -16 | -23 | -17 |
Income Taxes | 0 | 0 | 0 | 0 | -1 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 3 | -8 | -16 | -22 | -17 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 3 | -8 | -16 | -22 | -17 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 4 | -4 | -17 | -22 | -17 |
Depreciation & Amortization (Cash Flow) | 0 | 3 | 1 | 1 | 1 |
Income After Depreciation & Amortization | 3 | -7 | -18 | -23 | -17 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 153.96 | 138.03 | 107.82 | 99.91 | 97.86 |
Diluted EPS Before Non-Recurring Items | 0.02 | -0.07 | -0.14 | -0.22 | -0.17 |
Diluted Net EPS (GAAP) | 0.02 | -0.07 | -0.14 | -0.22 | -0.17 |
Fiscal Year end for CV Sciences, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 3.95 | 4.00 | 3.80 | 4.09 | 3.97 |
Cost Of Goods | 2.09 | 2.15 | 2.06 | 2.25 | 2.25 |
Gross Profit | 1.86 | 1.85 | 1.74 | 1.84 | 1.72 |
SG&A, R&D, and Dept/Amort Expenses | 2.45 | 2.48 | 2.63 | 2.28 | 2.80 |
Income After SG&A, R&D, and Dept/Amort Expenses | -0.59 | -0.63 | -0.89 | -0.44 | -1.08 |
Non-Operating Income | 0.00 | 0.00 | -0.05 | -0.01 | -0.21 |
Interest Expense | 0.00 | 0.00 | -0.06 | 0.00 | 0.00 |
Pretax Income | -0.58 | -0.62 | -0.88 | -0.45 | -1.29 |
Income Taxes | 0.00 | 0.01 | -0.01 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -0.58 | -0.63 | -0.87 | -0.45 | -1.29 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -0.58 | -0.63 | -0.87 | -0.45 | -1.29 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 172.42 | 163.08 | 150.18 | 154.60 | 152.60 |
Diluted EPS Before Non-Recurring Items | 0.00 | 0.00 | -0.01 | 0.00 | -0.01 |
Diluted Net EPS (GAAP) | 0.00 | 0.00 | -0.01 | 0.00 | -0.01 |